Physician profile
Aamir Badruddin
NPI 1871769331
$3,563.88
in general payments reported to CMS, 2019-2025
17 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what 89% of Neurocritical Care providers received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2021: $33.59 · 2022: $312 · 2023: $1,213 · 2024: $473 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,496 · Food and Beverage: $1,433 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,495.96 |
| Food and Beverage | $1,433.42 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $1,027.43 | 2023 | |
| Imperative Care, INC | $758.53 | 2025 | Zoom 88-T Large Distal Platform |
| Stryker Corporation | $448.78 | 2023-2025 | Surpass Evolve, Trevo, Target |
| Medtronic, INC. | $444.15 | 2022-2025 | Pipeline, Onyx 18, Corevalve Evolut R |
| Penumbra, INC. | $329.38 | 2019-2025 | Penumbra System, Penumbra Coil 400 |
| Microvention, INC. | $212.58 | 2019-2023 | Web Aneurysm Embolization System |
| Balt USA, LLC | $139.69 | 2024 | Optima Coil System |
| Microtransponder, INC. | $33.09 | 2024 | |
| Chiesi USA, INC. | $32.51 | 2024 | Cleviprex, Kengreal |
| Globus Medical, INC. | $28.89 | 2021-2023 | Excelsiusgps Robotic Navigation System |
| Cordis US Corp. | $27.20 | 2024-2025 | Mynx Control Venous, Mynxgrip |
| Depuy Synthes Sales INC. | $23.03 | 2025 | Fibergraft Aeridyan Matrix, Symphony, Fibergraft Bg Morsels |
| Csl Behring | $20.00 | 2024 | Kcentra |
| E.R. Squibb & Sons, L.L.C. | $19.86 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.76 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamir Badruddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.